相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo
Travis W. Hein et al.
ATHEROSCLEROSIS (2009)
C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
Sridevi Devaraj et al.
CARDIOVASCULAR RESEARCH (2009)
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study
J. S. Rana et al.
HEART (2009)
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Olle Melander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Paul Elliott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Association of Serum C-Reactive Protein Level with Sex-Specific Type 2 Diabetes Risk: A Prospective Finnish Study
Gang Hu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
Bayesian meta-analysis of genetic association studies with different sets of markers
Claudio Verzilli et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study
Himabindu Vidula et al.
ANNALS OF INTERNAL MEDICINE (2008)
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Peter W. F. Wilson et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2008)
Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation
J. Danesh et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genetically elevated C-reactive protein and ischemic vascular disease
Jeppe Zacho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies
Jennifer K. Pai et al.
PLOS ONE (2008)
The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants
Debbie A. Lawlor et al.
PLOS ONE (2008)
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects
Radjesh J. Bisoendial et al.
JOURNAL OF LIPID RESEARCH (2007)
Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study
Ioanna Tzoulaki et al.
EUROPEAN HEART JOURNAL (2007)
Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events
Leslie A. Lange et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Genetic variation is associated with C-reactive protein levels in the third national health and nutrition examination survey
Dana C. Crawford et al.
CIRCULATION (2006)
High serum C-reactive protein level is not an independent predictor for stroke - The Rotterdam Study
Michiel J. Bos et al.
CIRCULATION (2006)
CRP promotes monocyte-endothelial cell adhesion via Fcγ receptors in human aortic endothelial cells under static and shear flow conditions
Sridevi Devaraj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Insight into the nature of the CRP-coronary event association using Mendelian randomization
Juan P. Casas et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Nancy R. Cook et al.
ANNALS OF INTERNAL MEDICINE (2006)
Targeting C-reactive protein for the treatment of cardiovascular disease
MB Pepys et al.
NATURE (2006)
C-reactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells -: Implications for clinical and subclinical atherosclerosis
I Montero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level
S Kathiresan et al.
CIRCULATION (2006)
C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin
N Abe et al.
LIFE SCIENCES (2006)
Relationship between C-reactive protein and subclinical atherosclerosis - The Dallas Heart Study
A Khera et al.
CIRCULATION (2006)
Letter to the editor
R Bisoendial et al.
CIRCULATION RESEARCH (2005)
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
NJ Timpson et al.
LANCET (2005)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study
PWF Wilson et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
FcγRIIB mediates C-reactive protein inhibition of endothelial NO synthase
C Mineo et al.
CIRCULATION RESEARCH (2005)
Effect of Rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
A Verma et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Association of common CRP gene variants with CRP levels and cardiovascular events
DT Miller et al.
ANNALS OF HUMAN GENETICS (2005)
C-reactive protein in atherosclerotic lesions - Its origin and pathophysiological significance
HJ Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells - Evidence that C-reactive protein is a procoagulant
U Singh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
P Cirillo et al.
CARDIOVASCULAR RESEARCH (2005)
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population - Edinburgh Artery Study
I Tzoulaki et al.
CIRCULATION (2005)
Local release of C-reactive protein from vulnerable plaque or coronary arterial wall in injured by stenting
T Inoue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women - The cardiovascular health study
M Cushman et al.
CIRCULATION (2005)
Binding and internalization of C-reactive protein by fcgamma receptors on human aortic endothelial cells mediates biological effects
S Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level
AJ Szalai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase
E Qamirani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Activation of inflammation and coagulation after infusion of C-reactive protein in humans
RJ Bisoendial et al.
CIRCULATION RESEARCH (2005)
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
C Kistorp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability
BR Clapp et al.
CIRCULATION (2005)
Lovastatin reduces nuclear factor kappa B activation induced by C-reactive protein in human vascular endothelial cells
R Lin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappa B activation and C-reactive protein expression in human carotid artery plaques
KJE Sattler et al.
STROKE (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany
W Koenig et al.
CIRCULATION (2004)
Effect of C-reactive protein on chemokine expression in human aortic endothelial cells
S Devaraj et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells
W Suh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study
MK Rutter et al.
CIRCULATION (2004)
Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa
DE Manolov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus
AI Russell et al.
HUMAN MOLECULAR GENETICS (2004)
C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc gamma RII and extracellular signal-regulated kinase pathway: An implication of CRP involvement in plaque destabilization
TN Williams et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
FcγRIIa expression with FcγRI results in C-reactive protein and IgG-mediated phagocytosis
KB Bodman-Smith et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
C-reactive protein enhances LOX-1 expression in human aortic endothelial cells - Relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction
L Li et al.
CIRCULATION RESEARCH (2004)
C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function - Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease
S Verma et al.
CIRCULATION (2004)
C-reactive protein does not directly induce tissue factor in human monocytes
E Paffen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
C-reactive protein and the risk of developing hypertension
HD Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study
M Cesari et al.
CIRCULATION (2003)
Human CRP gene polymorphism influences CRP levels - Implications for the prediction and pathogenesis of coronary heart disease
DJ Brull et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
C-reactive protein decreases prostacyclin release from human aortic endothelial cells
SK Venugopal et al.
CIRCULATION (2003)
C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs
JR Turk et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging
DB Reuben et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Interaction of oxidative stress and inflammatory response in coronary plaque instability - Important role of C-reactive protein
S Kobayashi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly - The Cardiovascular Health Study
JJ Cao et al.
CIRCULATION (2003)
C-reactive protein activates complement in infarcted human myocardium
R Nijmeijer et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients
HP Kopp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
C-reactive protein and the future risk of thromboembolic stroke in healthy men
JD Curb et al.
CIRCULATION (2003)
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial
K Esposito et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle
CH Wang et al.
CIRCULATION (2003)
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells
S Devaraj et al.
CIRCULATION (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events
PM Ridker et al.
CIRCULATION (2003)
C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree - The Rotterdam study
IM van der Meer et al.
STROKE (2002)
Associations between cardiorespiratory fitness and C-reactive protein in men
TS Church et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI)
KB Bodman-Smith et al.
IMMUNOLOGY (2002)
Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells
SK Venugopal et al.
CIRCULATION (2002)
Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults
ES Ford
EPIDEMIOLOGY (2002)
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease - Prospective analysis from the Women's Health Initiative observational study
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
A self-fulfilling prophecy - C-reactive protein attenuates nitric oxide production and inhibits angiogenesis
S Verma et al.
CIRCULATION (2002)
Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women
MJ LaMonte et al.
CIRCULATION (2002)
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein
S Verma et al.
CIRCULATION (2002)
Physical activity and hemostatic and inflammatory variables in elderly men
SG Wannamethee et al.
CIRCULATION (2002)
Weight loss reduces C-reactive protein levels in obese postmenopausal women
A Tchernof et al.
CIRCULATION (2002)
Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene
AJ Szalai et al.
GENES AND IMMUNITY (2002)
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack - The Framingham Study
NS Rost et al.
STROKE (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
C-reactive protein in ischemic stroke - An independent prognostic factor
M Di Napoli et al.
STROKE (2001)
Generation of C-reactive protein and complement components in atherosclerotic plaques
K Yasojima et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.
B Lindahl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons
J Gussekloo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
C Kalka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
